CIK: 0001400240 · Show all filings
Period: Q3 2021 (← Previous) (Next →)
Filing Date: Nov 15, 2021
Total Value ($000): $9,549,130 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| MRNA | Moderna Inc | 17,581,016 | $6,766,230 | 70.9% | $16.43 | +2144.2% | COM | 60770K107 |
| SANA | Sana Biotechnology Inc | 34,239,018 | $771,063 | 8.1% | $32.56 | -35.5% | COM | 799566104 |
| — | Rubius Therapeutics Inc | 38,506,526 | $688,497 | 7.2% | $24.00 | — | COM | 78116T103 |
| — | Omega Therapeutics Inc | 25,902,269 | $488,258 | 5.1% | $18.85 | — | COM | 68217N105 |
| FHTX | Foghorn Therapeutics Inc | 12,674,120 | $176,551 | 1.8% | $19.16 | -42.2% | COM | 344174107 |
| — | Evelo Biosciences Inc | 23,030,069 | $162,131 | 1.7% | $10.39 | — | COM | 299734103 |
| DNLI | Denali Therapeutics Inc | 2,730,263 | $137,742 | 1.4% | $17.97 | +213.6% | COM | 24823R105 |
| KLDO | Kaleido Biosciences Inc | 19,575,710 | $106,883 | 1.1% | $13.01 | -52.3% | COM | 483347100 |
| — | Seres Therapeutics Inc | 14,378,802 | $100,076 | 1.0% | $8.55 | — | COM | 81750R102 |
| — | Sigilon Therapeutics Inc | 10,370,369 | $58,592 | 0.6% | $48.03 | — | COM | 82657L107 |
| — | Codiak Biosciences Inc | 2,607,303 | $42,578 | 0.4% | $32.30 | — | COM | 192010106 |
| — | Axcella Health Inc | 12,548,414 | $37,394 | 0.4% | $8.17 | — | COM | 05454B105 |
| — | Syros Pharmaceuticals Inc | 2,938,494 | $13,135 | 0.1% | $13.87 | — | COM | 87184Q107 |